The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 10, 2007
Filed:
May. 12, 2000
Jiangchun Xu, Bellevue, WA (US);
Davin C. Dillon, Issaquah, WA (US);
Jennifer L. Mitcham, Redmond, WA (US);
Susan L. Harlocker, Seattle, WA (US);
Yuqiu Jiang, Kent, WA (US);
Michael D. Kalos, Seattle, WA (US);
Gary R. Fanger, Mill Creek, WA (US);
Marc W. Retter, Carnation, WA (US);
John A. Stolk, Bothell, WA (US);
Craig H. Day, Seattle, WA (US);
Thomas S. Vedvick, Federal Way, WA (US);
Darrick Carter, Seattle, WA (US);
Samuel X. LI, Redmond, WA (US);
Aijun Wang, Issaquah, WA (US);
Yasir A. W. Skeiky, Bellevue, WA (US);
William T. Hepler, Seattle, WA (US);
Jiangchun Xu, Bellevue, WA (US);
Davin C. Dillon, Issaquah, WA (US);
Jennifer L. Mitcham, Redmond, WA (US);
Susan L. Harlocker, Seattle, WA (US);
Yuqiu Jiang, Kent, WA (US);
Michael D. Kalos, Seattle, WA (US);
Gary R. Fanger, Mill Creek, WA (US);
Marc W. Retter, Carnation, WA (US);
John A. Stolk, Bothell, WA (US);
Craig H. Day, Seattle, WA (US);
Thomas S. Vedvick, Federal Way, WA (US);
Darrick Carter, Seattle, WA (US);
Samuel X. Li, Redmond, WA (US);
Aijun Wang, Issaquah, WA (US);
Yasir A. W. Skeiky, Bellevue, WA (US);
William T. Hepler, Seattle, WA (US);
Corixa Corporation, Hamilton, MT (US);
Abstract
Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.